CYCN (STOCKS)
Cyclerion Therapeutics, Inc. Common Stock
$2.850300
-0.059700 (-2.05%)
Prev close: $2.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Regina Graul
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12.51M
- Employees
- 1
- P/E (TTM)
- -2.46
- P/B (TTM)
- 1.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $2.07M |
| Benefits Costs and Expenses | $5.60M |
| Costs And Expenses | $5.60M |
| Nonoperating Income/Loss | $1.45M |
| Operating Expenses | $7.05M |
| Research and Development | $959.00K |
| Other Operating Expenses | $6.09M |
| Operating Income/Loss | -$4.97M |
| Income/Loss From Continuing Operations After Tax | -$3.53M |
| Income/Loss From Continuing Operations Before Tax | -$3.53M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$3.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.53M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.11 |
| Diluted Earnings Per Share | -$1.11 |
| Basic Average Shares | 3,181,000 |
| Diluted Average Shares | 3,181,000 |
| Assets | $9.99M |
| Current Assets | $4.64M |
| Prepaid Expenses | $384.00K |
| Other Current Assets | $4.25M |
| Noncurrent Assets | $5.35M |
| Liabilities | $900.00K |
| Current Liabilities | $900.00K |
| Accounts Payable | $508.00K |
| Wages | $13.00K |
| Other Current Liabilities | $379.00K |
| Noncurrent Liabilities | $0.00 |
| Commitments and Contingencies | $0.00 |
| Equity | $9.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.09M |
| Liabilities And Equity | $9.99M |
| Net Cash Flow From Operating Activities | -$3.31M |
| Net Cash Flow From Operating Activities, Continuing | -$3.31M |
| Net Cash Flow From Investing Activities | -$8.00K |
| Net Cash Flow From Investing Activities, Continuing | -$8.00K |
| Net Cash Flow From Financing Activities | $3.32M |
| Net Cash Flow From Financing Activities, Continuing | $3.32M |
| Exchange Gains/Losses | $0.00 |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$3.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.53M |
| Other Comprehensive Income/Loss | $0.00 |